Suven Pharmaceuticals informs about transcript of conference call

14 Aug 2023 Evaluate

Pursuant to Regulation 30 read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Suven Pharmaceuticals has informed that it enclosed the transcript of the earnings conference call for the quarter ended June 30, 2023 conducted after the meeting of Board of Directors held on August 08, 2023. The above information has been uploaded on the Company's website.

The above information is a part of company’s filings submitted to BSE.

Cohance Lifesciences Share Price

386.55 2.35 (0.61%)
22-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1634.40
Dr. Reddys Lab 1217.15
Cipla 1371.55
Zydus Lifesciences 884.85
Lupin 2165.05
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×